RA Capital Management »

Benitec Biopharma shares owned by RA Capital Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $25M 1.9M 13.47

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Cidara Therapeutics SH (CDTX)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Vaxcyte SH (PCVX)
Sionna Therapeutics SH (SION)
Newamsterdam Pharma Co Nv SH (NAMS)
Tyra Biosciences SH (TYRA)
Wave Life Sciences SH (WVE)
Mineralys Therapeutics SH (MLYS)
Edgewise Therapeutics SH (EWTX)
Septerna SH (SEPN)
Nuvalent Inc-a SH (NUVL)
Disc Medicine SH (IRON)
Janux Therapeutics SH (JANX)

View all positions for RA Capital Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management
Geode Capital Management
AWM Investment Company

View all funds holding Benitec Biopharma